Table 2.
Epigenetic changes of CD8+ T cells in different autoimmune diseases.
| Diseases | Involved organs/cells | Epigenetic changes | Species | Functions | References |
|---|---|---|---|---|---|
| GD | Thyroid | Hypermethylation of LCK, CD247, ZAP70, CD3D, CD3E, CD3G, CTLA4 and PDCD1, LAX1 and SLA2, and CD8A | Human | Disturbing the activation and regulation of CD8+ T cells | (123) |
| GD | Thyroid | Reduced H3K4me3 and H3K27ac of CD247, CD3E, CD3G, LCK, ZAP70, and CTLA4 | Human | Involved in the activation of CD8+ T cells | (123) |
| GD | Thyroid | Reduced miRNA-200a_1 and miRNA-200a2* | Human | Assisting CD8+ T cells producing thyroid cell-specific antibodies | (122) |
| MS | CNS | Hypermethylation of MORN1 | Not mentioned | (100) | |
| MS | CNS | Increased miR-16, miR-155 and miR-142-3p | Human | Inhibiting Treg-suppressive activity | (124–126) |
| SSc | Skin | Hypomethylation of IFI44L, IFITM1, MX1, PARP9 | Human | Activation of Wnt signaling | (127, 128) |
| T1D | β cells and pancreas | Increased miR-29b | Mice | Impairing the cytotoxicity of CD8+ T cells | (129) |
| SLE | Multi-organs | Hypomethylation of PRF | Human | Enhancing the cytotoxicity of CD8+ T cells | (56, 116) |
| SAA | Hematopoietic cells | Hypomethylation of LAT | Mice | Enhancing the cytotoxicity of CD8+ T cells | (130) |
| SAA | Hematopoietic cells | Increased histone H3 acetylation | Human | Enhancing the cytotoxicity of CD8+ T cells | (131) |